Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ZC4H2 Foundation is a non-profit organization dedicated to advancing research and finding treatments for ZC4H2-associated rare disorders (ZARD). ZARD is a group of ultra-rare genetic conditions characterized by neuromuscular symptoms, joint contractures, and developmental delays. The foundation focuses on building a patient registry, funding scientific research, and fostering collaborations between clinicians and researchers globally. Their primary objective is to accelerate the development of therapeutic interventions, including gene-based therapies and small molecule treatments. By raising awareness and providing support to affected families, the foundation serves as a central hub for the ZARD community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZC4H2 Foundation.